Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Review
.
Show all posts
Showing posts with label
Review
.
Show all posts
Thursday, May 7, 2026
Aldeyra Therapeutics Announces FDA Acceptance for Review of Reproxalap New Drug Application for the Treatment of Dry Eye Disease
›
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) announced the U.S. Food and Drug Administration (FDA) acceptance the review of the...
Thursday, March 7, 2019
FDA Grants Priority Review for Daiichi Sankyo’s New Drug Application for CSF1R Inhibitor Pexidartinib for Treatment of Patients with TGCT, a Rare, Debilitating Tumor
›
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that the U.S. Food and Drug Administration (FDA) has accepted a...
›
Home
View web version
